重组Anti-PLK1抗体[EPR19534]
Anti-PLK1 antibody [EPR19534]
- RabMAb
- Recombinant
- 了解详情
Be the first to review this product! Submit a review
|
(18 Publications)
Rabbit Recombinant Monoclonal PLK1 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 18 publications.
查看别名
PLK, PLK1, Serine/threonine-protein kinase PLK1, Polo-like kinase 1, Serine/threonine-protein kinase 13, PLK-1, STPK13
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-PLK1 antibody [EPR19534] (AB189139)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed HeLa (Human epithelial cell line from cervix adenocarcinoma) cells labeling PLK1with ab189139 at 1/60 dilution (red) compared with a Rabbit IgG,monoclonal [EPR25A]-Isotype control (ab172730) (black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat anti Rabbit IgG (Alexa Fluorr® 488) at 1/2000 dilution was used as the secondary antibody.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-PLK1 antibody [EPR19534] (AB189139)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa (Human epithelial cell line from cervix adenocarcinoma) cells labeling PLK1 with ab189139 at 1/500 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green).
Confocal image showing strong signal staining on midbody and kinetochore of HeLa cell line.
The nuclear counterstain is DAPI (blue).
Tubulin is detected with ab195889 (Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594)) at 1/200 dilution (red).
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) at 1/1000 dilution.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-PLK1 antibody [EPR19534] (AB189139)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed K562 (Human chronic myelogenous leukemia cell line from bone marrow) cells labeling PLK1with ab189139 at 1/60 dilution (red) compared with a Rabbit IgG,monoclonal [EPR25A]-Isotype control (ab172730) (black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat anti Rabbit IgG (Alexa Fluorr® 488) at 1/2000 dilution was used as the secondary antibody.
- IP
Supplier Data
Immunoprecipitation - Anti-PLK1 antibody [EPR19534] (AB189139)
PLK1 was immunoprecipitated from 0.35 mg of K562 (Human chronic myelogenous leukemia cell line from bone marrow) whole cell lysate with ab189139 at 1/30 dilution.
Western blot was performed from the immunoprecipitate using ab189139 at 1/1000 dilution.
VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : K562 whole cell lysate, 10μg (Input).
Lane 2 : ab189139 IP in K562 whole cell lysate.
Lane 3 : Rabbit IgG,monoclonal [EPR25A]- Isotype Control (ab172730) instead of ab189139 in K562 whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds.
All lanes:
Immunoprecipitation - Anti-PLK1 antibody [EPR19534] (ab189139)
Predicted band size: 68 kDa
false
- WB
Supplier Data
Western blot - Anti-PLK1 antibody [EPR19534] (AB189139)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : Lane 1 and 2 : 30 seconds; Lane 3 and 4 : 3 minutes.
The expression profile observed is consistent with what has been described in the literature (PMID : 21545375).
All lanes:
Western blot - Anti-PLK1 antibody [EPR19534] (ab189139) at 1/1000 dilution
Lane 1:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
K562 (Human chronic myelogenous leukemia cell line from bone marrow) whole cell lysate at 20 µg
Lane 3:
PC-3 (Human prostate adenocarcinoma cell line) whole cell lysate at 20 µg
Lane 4:
HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 68 kDa
Observed band size: 68 kDa
false
不同偶联物与剂型 (7)
-
Anti-PLK1 antibody [EPR19534] - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-PLK1 antibody [EPR19534]
-
578 PE
PE Anti-PLK1 antibody [EPR19534]
-
660 APC
APC Anti-PLK1 antibody [EPR19534]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-PLK1 antibody [EPR19534]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-PLK1 antibody [EPR19534]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-PLK1 antibody [EPR19534]
反应性数据
产品详情
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (18)
Recent publications for all applications. Explore the full list and refine your search
Discover oncology 16:1047 PubMed40493298
2025
Applications
Unspecified application
Species
Unspecified reactive species
Pharmaceutics 17: PubMed40430849
2025
Applications
Unspecified application
Species
Unspecified reactive species
Open medicine (Warsaw, Poland) 19:20240971 PubMed38841177
2024
Applications
Unspecified application
Species
Unspecified reactive species
Pharmaceutics 15: PubMed38140096
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 14:695 PubMed37872147
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nucleic acids research 51:10568-10589 PubMed37739411
2023
Applications
Unspecified application
Species
Unspecified reactive species
BioMed research international 2022:7848771 PubMed35941968
2022
Applications
Unspecified application
Species
Unspecified reactive species
BMC cancer 22:666 PubMed35715760
2022
Applications
Unspecified application
Species
Unspecified reactive species
Acta pharmaceutica Sinica. B 12:3861-3876 PubMed36213538
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cell science 135: PubMed35044463
2022
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com